Effect of E-coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model

被引:34
作者
Liebregts, T
Adam, B
Bertel, A
Jones, S
Schulze, J
Enders, C
Sonnenborn, U
Lackner, K
Holtmann, G [1 ]
机构
[1] Univ Adelaide, Royal Adelaide Hosp, Dept Gastroenterol Hepatol & Gen Med, Adelaide, SA 5000, Australia
[2] Univ Essen Gesamthsch, Dept Internal Med, Div Gastroenterol & Hepatol, Essen, Germany
[3] Ardeypharm GmbH, Herdecke, Germany
[4] Graz Univ, Inst Pathol, A-8010 Graz, Austria
关键词
post-inflammatory; E. coli Nissle; visceral hyperalgesia;
D O I
10.1111/j.1365-2982.2005.00638.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Visceral hyperalgesia (VH) plays a key role for the manifestation of functional gastrointestinal (GI) disorders. In a subgroup of patients, the initial manifestation is preceded by GI inflammation. Recent studies have demonstrated an improvement of inflammation and symptoms during treatment with Escherichia coli Nissle 1917 (EcN). Aim: We aimed to characterize the effects of EcN on visceral sensitivity in a rat model of post-inflammatory VH. Methods: Male Lewis rats underwent colorectal instillation of trinitrobenzenesulphonic acid (TNBS) plus an equal amount of ethanol (test group) or physiological saline solution (control group). After 28, 35 and 42 days, standardized colorectal distensions were performed and the visceromotor reflex (VMR) of abdominal wall muscles was quantified by electromyographic recording. From day 28 onwards, EcN was administered in drinking water. Results: After TNBS, a significant increase of VMR was observed compared with saline controls over all study days. Administration of EcN reduced the TNBS-induced hyperalgesia [EcN: 863 +/- 125 mu V vs placebo: 1258 +/- 157 mu V (P < 0.05)] at day 35, while there were no significant alterations at any other study day. Conclusion: The EcN administration caused a significant reduction of VH. Whether EcN might play a role in the treatment of post-infectious functional bowel disorders remains to be investigated in further studies.
引用
收藏
页码:410 / 414
页数:5
相关论文
共 31 条
[1]
The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens [J].
Altenhoefer, A ;
Oswald, S ;
Sonnenborn, U ;
Enders, C ;
Schulze, J ;
Hacker, J ;
Oelschlaeger, TA .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2004, 40 (03) :223-229
[2]
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome [J].
Barbara, G ;
Stanghellini, V ;
De Giorgio, R ;
Cremon, C ;
Cottrell, GS ;
Santini, D ;
Pasquinelli, G ;
Morselli-Labate, AM ;
Grady, EF ;
Bunnett, NW ;
Collins, SM ;
Corinalidesi, R .
GASTROENTEROLOGY, 2004, 126 (03) :693-702
[3]
PROPERTIES OF ESCHERICHIA-COLI STRAINS OF SEROTYPE O6 [J].
BLUM, G ;
MARRE, R ;
HACKER, J .
INFECTION, 1995, 23 (04) :234-236
[4]
Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria [J].
Cross, ML ;
Ganner, A ;
Teilab, D ;
Fray, LM .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2004, 42 (02) :173-180
[5]
DOTEVALL G, 1982, SCAND J GASTROENTERO, V17, P124
[6]
THE IRRITABLE-BOWEL-SYNDROME - REVIEW AND A GRADUATED MULTICOMPONENT TREATMENT APPROACH [J].
DROSSMAN, DA ;
THOMPSON, WG .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (12) :1009-1016
[7]
DROSSMAN DA, 1985, CLIN GASTROENTEROL, V14, P559
[8]
Long-term effects of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension [J].
Gschossmann, JM ;
Liebregts, T ;
Adam, B ;
Buenger, L ;
Ruwe, M ;
Gerken, G ;
Holtmann, G .
DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (01) :96-101
[9]
Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls [J].
Holtmann, G ;
Gschossmann, J ;
Neufang-Hüber, J ;
Gerken, G ;
Talley, NJ .
GUT, 2000, 47 (03) :332-336
[10]
Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis [J].
Kruis, W ;
Schutz, E ;
Fric, P ;
Fixa, B ;
Judmaier, G ;
Stolte, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (05) :853-858